Fabisiak, A.; Bartoszek, A.; Talar, M.; Binienda, A.; Dziedziczak, K.; Krajewska, J.B.; Mosińska, P.; Niewinna, K.; Tarasiuk, A.; Mokrowiecka, A.;
et al. Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease. J. Clin. Med. 2020, 9, 4111.
https://doi.org/10.3390/jcm9124111
AMA Style
Fabisiak A, Bartoszek A, Talar M, Binienda A, Dziedziczak K, Krajewska JB, Mosińska P, Niewinna K, Tarasiuk A, Mokrowiecka A,
et al. Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease. Journal of Clinical Medicine. 2020; 9(12):4111.
https://doi.org/10.3390/jcm9124111
Chicago/Turabian Style
Fabisiak, Adam, Adrian Bartoszek, Marcin Talar, Agata Binienda, Katarzyna Dziedziczak, Julia B. Krajewska, Paula Mosińska, Karolina Niewinna, Aleksandra Tarasiuk, Anna Mokrowiecka,
and et al. 2020. "Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease" Journal of Clinical Medicine 9, no. 12: 4111.
https://doi.org/10.3390/jcm9124111
APA Style
Fabisiak, A., Bartoszek, A., Talar, M., Binienda, A., Dziedziczak, K., Krajewska, J. B., Mosińska, P., Niewinna, K., Tarasiuk, A., Mokrowiecka, A., Wierzchniewska-Ławska, A., Małecka-Panas, E., Salaga, M., & Fichna, J.
(2020). Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease. Journal of Clinical Medicine, 9(12), 4111.
https://doi.org/10.3390/jcm9124111